The effect of lithium chloride on morphine-induced tolerance and dependence in isolated guinea pig ileum

European Journal of Pharmacology

Volumn 545, Issue 2-3, 2006, Pages 123-128

  Alborzi, Afsaneh ^a   Mehr, Shahram Ejtemaei ^a   Rezania, Fatemeh ^a   Badakhshan, Setareh ^a   Mombeini, Tajmah ^b   Shafaroodi, Hamed ^c   Moezi, Leila ^a   Ravan, Mohammadreza Nick ^a   Sharifian, Mahdiyeh ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHED UNIVERSITY   (Iran)

^c Medical Research Group   (Iran)

Author keywords

Dependence; Guinea pig; Ileum; Lithium; Morphine; Tolerance

Indexed keywords

LITHIUM CHLORIDE; MORPHINE; NALOXONE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROSTIMULATION; GUINEA PIG; IC 50; ILEUM; ILEUM CONTRACTION; INCUBATION TIME; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; GUINEA PIGS; ILEUM; LITHIUM CHLORIDE; MALE; MORPHINE; MORPHINE DEPENDENCE; MUSCLE CONTRACTION; NITRIC OXIDE;

EID: 33747608627     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.061     Document Type: Article

References (40)

1. Abajo F.J., Castro M.A., Garijo B., and Sanchez-Garcia P. Catecholamine release evoked by lithium from the perfused adrenal gland of the cat. Br. J. Pharmacol. 91 (1987) 539-546
2. Adams M.L., Kalicki J.M., Meyer E.R., and Cicero T.J. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-l-arginine methyl ester. Life Sci. 52 (1993) PL245-PL249
3. Baeyens J.M., Esposito E., Ossowska G., and Samanin R. Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats. Eur. J. Pharmacol. 137 (1987) 9-13
4. Berridge M.J., and Irvine R.F. Inositol phosphates and cell signalling. Nature 341 (1989) 197-205
5. Berridge M.J., Downes C.P., and Hanley M.R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206 (1982) 587-595
6. Bongianni F., Carla V., Moroni F., and Pellegrini-Giampietro D.E. Calcium channel inhibitors suppress the morphine-withdrawal syndrome in rats. Br. J. Pharmacol. 88 (1986) 561-567
7. Bradford H.F., and Crowder J.M. White EJ Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices. Br. J. Pharmacol. 88 (1986) 87-93
8. Brunello N., and Tascedda F. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Int. J. Neuropsychopharmacol. 6 (2003) 181-189
9. Capasso A., Sorrentino L., and Pinto A. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists. Eur. J. Pharmacol. 359 (1998) 127-131
10. Cappendijk S.L., de Vries R., and Dzoljic M.R. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 162 (1993) 97-100
11. Chakrabarti S., Wang L., Tang W.J., and Gintzler A.R. Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. Mol. Pharmacol. 54 (1998) 949-953
12. Collier H.O., Cuthbert N.J., and Francis D.L. Model of opiate dependence in the guinea-pig isolated ileum. Br. J. Pharmacol. 73 (1981) 921-932
13. Crowder J.M., Norris D.K., and Bradford H.F. Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes. Biochem. Pharmacol. 35 (1986) 2501-2507
14. Dambisya Y.M., and Lee T.L. Effects l-NG-nitro arginine methyl ester (l-NAME), l-NG-monomethyl arginine (l-NMMA) and l-arginine on the antinociceptive effects of morphine in mice. Methods Find Exp. Clin. Pharmacol. 17 (1995) 577-582
15. Dehpour A.R., Farsam H., and Azizabadi-Farahani M. The effect of lithium on morphine-induced analgesia in mice. Gen. Pharmacol. 25 (1994) 1635-1641
16. Dehpour A.R., Farsam H., and Azizabadi-Farahani M. Inhibition of the morphine withdrawal syndrome and the development of physical dependence by lithium in mice. Neuropharmacology 34 (1995) 115-121
17. Dehpour A.R., Rastegar H., Jorjani M., Roushanzamir F., Joharchi K., and Ahmadiani A. Subsensitivity to opioids is receptor-specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis. J. Pharmacol. Exp. Ther. 293 (2000) 946-951
18. Duman R.S., Tallman J.F., and Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246 (1988) 1033-1039
19. Guitart X., and Nestler E.J. Identification of morphine- and cyclic AMP-regulated phosphoproteins (MARPPs) in the locus coeruleus and other regions of rat brain: regulation by acute and chronic morphine. J. Neurosci. 9 (1989) 4371-4387
20. Haden S.T., Brown E.M., Stoll A.L., Scott J., and Fuleihan G.E. The effect of lithium on calcium-induced changes in adrenocorticotrophin levels. J. Clin. Endocrinol. Metab. 84 (1999) 198-200
21. Kanba S., Pfenning M., and Richelson E. Lithium ions inhibit function of low- but not high-affinity muscarinic receptors of murine neuroblastoma cells (clone N1E-115). Psychopharmacology (Berl.) 86 (1985) 413-416
22. Kanba S., Pfenning M., Kanba K.S., and Richelson E. Lithium ions have a potent and selective inhibitory effect on cyclic GMP formation stimulated by neurotensin, angiotensin II and bradykinin. Eur. J. Pharmacol. 126 (1986) 111-116
23. Kofman O., and Patishi Y. Interactions of lithium and drugs that affect signal transduction on behaviour in rats. Eur. Neuropsychopharmacol. 9 (1999) 385-397
24. Liebman J.M., and Segal D.S. Lithium differentially antagonises self-stimulation facilitated by morphine and (+)-amphetamine. Nature 260 (1976) 161-163
25. Lujan M., and Rodriguez R. Pharmacological characterization of opiate physical dependence in the isolated ileum of the guinea-pig. Br. J. Pharmacol. 73 (1981) 859-866
26. Mork A., and Geisler A. Mode of action of lithium on the catalytic unit of adenylate cyclase from rat brain. Pharmacol. Toxicol. 60 (1987) 241-248
27. Nestler E.J. Molecular mechanisms of opiate and cocaine addiction. Curr. Opin. Neurobiol. 7 (1997) 713-719
28. Newman M.E., and Belmaker R.H. Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology 26 (1987) 211-217
29. Ramkumar V., and El-Fakahany E.E. Increase in [3H] nitrendipine binding sites in the brain in morphine-tolerant mice. Eur. J. Pharmacol. 102 (1984) 371-372
30. Rezvani A., Huidobro-Toro J.P., Hu J., and Way E.L. A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro. J. Pharmacol. Exp. Ther. 225 (1983) 251-255
31. Rivera M., and Gintzler A.R. Differential effect of chronic morphine on mRNA encoding adenylyl cyclase isoforms: relevance to physiological sequela of tolerance/dependence. Brain Res. Mol. Brain Res. 54 (1998) 165-169
32. Saarnivaara L., and Mannisto P.T. Effects of lithium and rubidium on antinociception and behaviour in mice. I. Studies on narcotic analgesics and antagonists. Arch. Int. Pharmacodyn. Ther. 222 (1976) 282-292
33. Sharma S.K., Klee W.A., and Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 3092-3096
34. Sharma S.K., Klee W.A., and Nirenberg M. Opiate-dependent modulation of adenylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 74 (1977) 3365-3369
35. Sim-Selley L.J., Selley D.E., Vogt L.J., Childers S.R., and Martin T.J. Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J. Neurosci. 20 (2000) 4555-4562
36. Taylor D.A., and Fleming W.W. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J. Pharmacol. Exp. Ther. 297 (2001) 11-18
37. Tomkiewicz M., and Steinberg H. Lithium treatment reduces morphine self-administration in addict rats. Nature 15 252 (1974) 227-229
38. 2+ levels. J. Psychiatry Neurosci. 28 (2003) 115-125
39. Whistler J.L., Chuang H.H., Chu P., Jan L.Y., and von Zastrow M. Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23 (1999) 737-746
40. Zhang J., Ferguson S.S., Barak L.S., Bodduluri S.R., Laporte S.A., Law P.Y., and Caron M.G. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 7157-7162